Redmond Asset Management LLC Purchases Shares of 114,317 Cellebrite DI Ltd. $CLBT

Key Points

• Redmond Asset Management LLC invested $2.22 million in Cellebrite DI Ltd., acquiring 114,317 shares of the company's stock.
• Cellebrite DI has reported a revenue increase of 18.4% year-over-year, reaching $113.28 million, and surpassed earnings estimates with $0.12 earnings per share.
• Institutional investors now hold 45.88% of Cellebrite DI's stock, with several firms, including Invesco and Handelsbanken, significantly increasing their stakes recently.

Redmond Asset Management LLC bought a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 114,317 shares of the company's stock, valued at approximately $2,221,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CLBT. Assetmark Inc. bought a new stake in Cellebrite DI during the first quarter worth approximately $33,000. Catalyst Capital Advisors LLC bought a new position in shares of Cellebrite DI in the first quarter valued at $51,000. Gen Wealth Partners Inc bought a new position in shares of Cellebrite DI in the fourth quarter valued at $85,000. NewEdge Advisors LLC increased its holdings in shares of Cellebrite DI by 600.7% in the fourth quarter. NewEdge Advisors LLC now owns 3,910 shares of the company's stock valued at $86,000 after buying an additional 3,352 shares in the last quarter. Finally, Sigma Planning Corp bought a new position in shares of Cellebrite DI in the first quarter valued at $233,000. Institutional investors own 45.88% of the company's stock.

Analysts Set New Price Targets

Several research firms have issued reports on CLBT. Lake Street Capital dropped their price target on Cellebrite DI from $24.00 to $22.00 and set a "buy" rating on the stock in a report on Friday. Wall Street Zen raised Cellebrite DI from a "hold" rating to a "buy" rating in a report on Saturday. JPMorgan Chase & Co. cut their target price on shares of Cellebrite DI from $29.00 to $25.00 and set an "overweight" rating on the stock in a research note on Monday, May 12th. Finally, Needham & Company LLC cut their target price on shares of Cellebrite DI from $24.00 to $18.00 and set a "buy" rating on the stock in a research note on Thursday, August 14th. Five research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $22.40.

Cellebrite DI Price Performance

NASDAQ:CLBT traded down $0.36 during trading hours on Tuesday, reaching $15.80. The company's stock had a trading volume of 2,575,595 shares, compared to its average volume of 1,674,130. The company has a market cap of $3.78 billion, a price-to-earnings ratio of -20.79, a price-to-earnings-growth ratio of 2.92 and a beta of 1.27. Cellebrite DI Ltd. has a one year low of $13.10 and a one year high of $26.30. The business's 50-day moving average is $14.97 and its 200-day moving average is $17.68.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last issued its quarterly earnings data on Thursday, August 14th. The company reported $0.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.11 by $0.01. The firm had revenue of $113.28 million during the quarter, compared to analysts' expectations of $112.33 million. Cellebrite DI had a negative net margin of 34.56% and a positive return on equity of 25.28%. Cellebrite DI's revenue for the quarter was up 18.4% on a year-over-year basis. During the same period in the prior year, the company posted $0.10 earnings per share. Cellebrite DI has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, sell-side analysts predict that Cellebrite DI Ltd. will post 0.3 EPS for the current fiscal year.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.